- Home
- CFSB vs MRSN Comparison
CFSB vs MRSN Comparison
Compare CFSB & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFSB
- MRSN
- Stock Information
- Founded
- CFSB 1889
- MRSN 2001
- Country
- CFSB United States
- MRSN United States
- Employees
- CFSB N/A
- MRSN N/A
- Industry
- CFSB Major Banks
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- CFSB Finance
- MRSN Health Care
- Exchange
- CFSB Nasdaq
- MRSN Nasdaq
- Market Cap
- CFSB 50.1M
- MRSN 43.4M
- IPO Year
- CFSB N/A
- MRSN 2017
- Fundamental
- Price
- CFSB $7.85
- MRSN $0.39
- Analyst Decision
- CFSB
- MRSN Buy
- Analyst Count
- CFSB 0
- MRSN 3
- Target Price
- CFSB N/A
- MRSN $4.00
- AVG Volume (30 Days)
- CFSB 1.2K
- MRSN 3.1M
- Earning Date
- CFSB 05-02-2025
- MRSN 05-08-2025
- Dividend Yield
- CFSB N/A
- MRSN N/A
- EPS Growth
- CFSB N/A
- MRSN N/A
- EPS
- CFSB N/A
- MRSN N/A
- Revenue
- CFSB $7,462,000.00
- MRSN $40,497,000.00
- Revenue This Year
- CFSB N/A
- MRSN N/A
- Revenue Next Year
- CFSB N/A
- MRSN N/A
- P/E Ratio
- CFSB N/A
- MRSN N/A
- Revenue Growth
- CFSB N/A
- MRSN 9.88
- 52 Week Low
- CFSB $6.34
- MRSN $0.26
- 52 Week High
- CFSB $8.28
- MRSN $3.63
- Technical
- Relative Strength Index (RSI)
- CFSB 54.12
- MRSN 51.49
- Support Level
- CFSB $7.73
- MRSN $0.33
- Resistance Level
- CFSB $7.98
- MRSN $0.38
- Average True Range (ATR)
- CFSB 0.16
- MRSN 0.05
- MACD
- CFSB 0.02
- MRSN 0.02
- Stochastic Oscillator
- CFSB 81.94
- MRSN 76.70
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.